Eli Lilly, Novo Nordisk and Amgen release weight loss drug data as competition heats up in the market, while Abridge ...

Ozempic is a prescription medication made by Novo Nordisk and primarily used to treat patients with type 2 diabetes.

People living with an autoimmune disease are nearly twice as likely to suffer from mood problems like depression, anxiety or ...

Novo Nordisk A/S (NYSE:NVO) is a Danish pharmaceutical giant that is a key player in the weight loss drug market. The firm’s ...

Hims & Hers lost a valuable collaboration with Novo Nordisk over compounded GLP-1s. Could it hurt the company's potential to ...

Despite Novo Nordisk (NVO) recently ending a partnership with Hims & Hers Health (NYSE:HIMS) to distribute its weight-loss ...

The CATALYST meta-analysis pooled the four studies and identified 5,441 people with acute ischemic stroke and Afib for inclusion. The population largely came from OPTIMAS (67%), followed by the TIMING ...

Valo Health is growing its workforce as the Boston-area biotech expands to meet the needs of its partnerships, including a ...

Novo Nordisk is under fire over a Spanish obesity awareness campaign. | Novo Nordisk is under fire over a Spanish obesity ...

Eli Lilly’s tirzepatide is expected to be worth $62 billion annually by 2030, according to Evaluate. That valuation would be ...

The Pharmaceutical Automation and Digitalisation Congress (AUTOMA+) 2025 welcomes delegates to be a part of its 5th ...

Novo Nordisk NVO announced that it has ended its collaboration with telehealth provider Hims & Hers Health. In addition, the ...